Skip to main content
Log in

Enhanced Activation of Atrial Natriuretic Peptide (ANP) and Natriuretic Peptide Receptor-A (NPRA) in Chronic Cigarette Smoke-Induced Lung Inflammation in Experimental Rats

  • Published:
International Journal of Peptide Research and Therapeutics Aims and scope Submit manuscript

Abstract

We sought to determine the circulatory level of atrial natriuretic peptide (ANP) and its receptor (Natriuretic peptide receptor-A) on different (7, 15, 30 and 45) days of cigarette smoke (CS) exposure-induced pulmonary inflammatory condition in experimental rats. The plasma ANP and lung cGMP levels were measured using a commercial ELISA kit. The total cells count (TC), neutrophil (N), and macrophage (M) were quantitated in bronchoalveolar lavage fluid (BALF) isolated from CS and control rat lungs. In addition, mRNA and protein expression profile of natriuretic peptide receptor-A (NPRA) was also quantitated in experimental groups. The TC, N, and M were gradually increased and reached maximum on the 45th day (p < 0.001 respectively) in BALF isolated from CS exposed rat compared with control. Further, Inflammatory markers of histamine and serotonin levels were also progressively increased and reached the maximum at 45 days of CS rats (p < 0.001 respectively) compared with control. The plasma ANP (9.07 ± 0.57 vs 22.01 ± 0.67 pmol/ml) and lung cGMP (8.66 ± 0.80 vs 21.33 ± 0.98 pg/ml) levels were up-regulated starting from 7th day of exposure and reach a maximum on 45 days CS exposed rats (p < 0.001 respectively) as compared with control. Moreover, mRNA and protein expression of NPRA was increased gradually and reached the maximum (threefold and 3.5-fold respectively) on 45th day of CS exposure. Our results demonstrate for the first time that ANP/NPRA an intrinsic anti-inflammatory system of the lung is getting up-regulated during CS exposure.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Fig. 1
Fig. 2

Similar content being viewed by others

References

Download references

Acknowledgements

Dr. EV greatly acknowledges UGC-SAP DRS-II (F.5/2015/DRS-II (SAP-II)), India for the financial support. AB wishes to thank the UGC-SAP DRS-II (GCCO/A5/UGC-SAP-II) for junior research fellowship (JRF) also thanks the Indian Council of Medical Research (ICMR) (F.No.45/28/2020-BIO/BMS) for senior research fellowship (SRF).

Funding

Dr. EV greatly acknowledges UGC-SAP DRS-II (F.5/2015/DRS-II (SAP-II)), India, for the financial support.

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to Elangovan Vellaichamy.

Ethics declarations

Conflict of interest

All the authors declare no conflict of interest.

Ethical approval

All the animals studies were approved by the Institutional Animal Ethics Committee (IAEC) of the University of Madras IAEC No: 01/01/2018 and were performed in accordance with CPCSEA guidelines.

Additional information

Publisher's Note

Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Babu, A.A., Vellaichamy, E. Enhanced Activation of Atrial Natriuretic Peptide (ANP) and Natriuretic Peptide Receptor-A (NPRA) in Chronic Cigarette Smoke-Induced Lung Inflammation in Experimental Rats. Int J Pept Res Ther 27, 2543–2550 (2021). https://doi.org/10.1007/s10989-021-10271-3

Download citation

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s10989-021-10271-3

Keywords

Navigation